Fünf Aktien aus unterschiedlichen Branchen notieren knapp unter ihren 52-Wochen-Hochs. Ein Überblick über Treiber und Risiken ...

Axsome Therapeutics markiert derzeit ein neues 52-Wochen-Hoch nach dem anderen. Die Aktie kletterte am Donnerstag auf 201 Euro und setzt damit eine beeindruckende Serie fort. Allein im vergangenen ...

Im ersten Quartal 2026 kletterte der Umsatz um 57,4 Prozent auf 191,2 Millionen US-Dollar. Indes weitete sich der Verlust je Aktie auf 1,26 US-Dollar aus. Marktbeobachter hatten im Vorfeld lediglich ...

Axsome Therapeutics (NASDAQ: AXSM) shares soared to close out the year. The company released two items of news today. Investors see one in particular as a meaningful catalyst for the biopharmaceutical ...

Key Points Interested in Axsome Therapeutics, Inc.? Here are five stocks we like better. Axsome Therapeutics said it is on ...

Axsome Therapeutics AXSM is preparing to release its quarterly earnings on Monday, 2025-08-04. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect ...

Shares of biopharmaceutical company Axsome Therapeutics (NASDAQ: AXSM) had declined 6% at 11 a.m. ET today. The slump comes after the company announced the results of a phase 3 trial of solriamfetol ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM) (Axsome), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders ...

Shares of Axsome Therapeutics (NASDAQ: AXSM) are flying higher on Monday. The company's stock is up 24.7% as of 1:10 p.m. ET, gaining as much as 25% earlier in the day. The move up comes as the S&P ...

Axsome Therapeutics has three drugs on the market and five in the pipeline, with the potential to help some 150 million Americans suffering from brain disorders. When Herriot Tabuteau started a drug ...

Shares of Axsome Therapeutics (NASDAQ: AXSM) are up on Tuesday. The company's stock gained 4.1% as of 10:20 a.m. ET, but was up as much as 5.6% earlier in the day. The jump comes as the S&P 500 ...